Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

September 6, 2023

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

The Drug Enforcement Administration (DEA) published a document in the Federal Register of April 4, 2023, concerning a notice of application for bulk manufacturer of Controlled Substances. That document listed a drug code/controlled substance in error as it was not requested by the registrant (2270--Pentobarbital). Additionally, the document listed duplicates of 7 other drug codes in error (1100, 1105, 1205, 1724, 8333, 9780, 9801).

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 171 (Wednesday, September 6, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 171 (Wednesday, September 6, 2023)]
[Notices]
[Pages 60987-60988]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19179]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1176]


Bulk Manufacturer of Controlled Substances Application: SpecGx 
LLC; Correction

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) published a document 
in the Federal Register of April 4, 2023, concerning a notice of 
application for bulk manufacturer of Controlled Substances. That 
document listed a drug code/controlled substance in error as it was not 
requested by the registrant (2270--Pentobarbital). Additionally, the 
document listed duplicates of 7 other drug codes in error (1100, 1105, 
1205, 1724, 8333, 9780, 9801).

SUPPLEMENTARY INFORMATION: 

Correction

    In the Federal Register of April 4, 2023, in FR Doc. 2023-06952 (88 
FR 19990), on page 19990, in columns 1 and 2, under the requested 
controlled substances/drug codes, it should read as such:

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..............    2010  I
Tetrahydrocannabinols..................    7370  I
Psilocybin.............................    7437  I
Codeine-N-oxide........................    9053  I
Noroxymorphone.........................    9145  I
Difenoxin..............................    9168  I
Morphine-N-oxide.......................    9307  I
Normorphine............................    9313  I
Alphamethadol..........................    9605  I
Betamethadol...........................    9609  I
Norlevorphanol.........................    9634  I
Acetyl Fentanyl (N-(1-                     9821  I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide).
Butyryl Fentanyl.......................    9822  I
Fentanyl related-compounds as defined      9850  I
 in 21 CFR 1308.11(h).
Amphetamine............................    1100  II
Methamphetamine........................    1105  II
Lisdexamfetamine.......................    1205  II
Methylphenidate........................    1724  II
Nabilone...............................    7379  II
ANPP (4-Anilino-N-phenethyl-4-             8333  II
 piperidine).
Phenylacetone..........................    8501  II
Codeine................................    9050  II
Dihydrocodeine.........................    9120  II
Oxycodone..............................    9143  II
Hydromorphone..........................    9150  II
Diphenoxylate..........................    9170  II
Ecgonine...............................    9180  II
Hydrocodone............................    9193  II
Levorphanol............................    9220  II
Isomethadone...........................    9226  II
Meperidine.............................    9230  II
Meperidine intermediate-A..............    9232  II
Meperidine intermediate-B..............    9233  II
Meperidine intermediate-C..............    9234  II
Methadone..............................    9250  II
Methadone intermediate.................    9254  II
Dextropropoxyphene, bulk (non-dosage       9273  II
 forms).
Morphine...............................    9300  II
Oripavine..............................    9330  II
Thebaine...............................    9333  II
Opium tincture.........................    9630  II

[[Page 60988]]

 
Opium, powdered........................    9639  II
Oxymorphone............................    9652  II
Noroxymorphone.........................    9668  II
Alfentanil.............................    9737  II
Remifentanil...........................    9739  II
Sufentanil.............................    9740  II
Tapentadol.............................    9780  II
Fentanyl...............................    9801  II
------------------------------------------------------------------------


Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-19179 Filed 9-5-23; 8:45 am]
BILLING CODE P


</pre></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on September 6, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.